We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+9.93%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$30.4B
AUM Growth
+$3.48B
(+13%)
Cap. Flow
+$841M
Cap. Flow
% of AUM
2.77%
Top 10 Holdings %
Top 10 Hldgs %
10.11%
Holding
1,992
New
240
Increased
827
Reduced
644
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$151M |
| 2 |
Applied Materials
AMAT
|
+$145M |
| 3 |
Intuit
INTU
|
+$142M |
| 4 |
Humana
HUM
|
+$115M |
| 5 |
Sherwin-Williams
SHW
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Expedia Group
EXPE
|
+$177M |
| 2 |
Exelon
EXC
|
+$128M |
| 3 |
NXP Semiconductors
NXPI
|
+$124M |
| 4 |
UnitedHealth
UNH
|
+$119M |
| 5 |
PayPal
PYPL
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.39% |
| 2 | Healthcare | 14.41% |
| 3 | Financials | 14.4% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIVO
1351
DELISTED
Tivo Inc
TIVO
| $1.46M | ﹤0.01% |
172,669
-27,680
| -14% | -$219K |
|
1352
Kura Oncology
KURA
$922M
| $1.46M | ﹤0.01% |
105,939
-147,446
| -58% | -$2.18M |
|
|
TXNM
1353
TXNM Energy Inc
TXNM
$6.47B
| $1.42M | ﹤0.01% |
28,066
-72,251
| -72% | -$3.63M |
|
1354
Ingevity
NGVT
$2.55B
| $1.4M | ﹤0.01% |
+16,003
| New | +$1.4M |
|
1355
Winmark
WINA
$1.19B
| $1.39M | ﹤0.01% |
7,001
+790
| +13% | +$142K |
|
1356
Ethan Allen Interiors
ETD
$581M
| $1.39M | ﹤0.01% |
72,670
+15,170
| +26% | +$283K |
|
|
INVX
1357
Innovex International
INVX
$1.87B
| $1.38M | ﹤0.01% |
29,493
+15,498
| +111% | +$710K |
|
1358
OneMain Financial
OMF
$6.9B
| $1.38M | ﹤0.01% |
32,739
+3,727
| +13% | +$151K |
|
|
ILPT
1359
Industrial Logistics Properties Trust
ILPT
$613M
| $1.38M | ﹤0.01% |
+61,500
| New | +$1.32M |
|
1360
New Jersey Resources
NJR
$6.06B
| $1.37M | ﹤0.01% |
30,810
-3,474
| -10% | -$150K |
|
1361
Crown Castle
CCI
$32.7B
| $1.37M | ﹤0.01% |
9,628
| – | – |
|
|
SPLK
1362
DELISTED
Splunk Inc
SPLK
| $1.36M | ﹤0.01% |
9,111
+6,071
| +200% | +$797K |
|
1363
LiveRamp
RAMP
$2.29B
| $1.36M | ﹤0.01% |
28,342
-11,121
| -28% | -$500K |
|
1364
Kinsale Capital Group
KNSL
$7.95B
| $1.36M | ﹤0.01% |
13,400
+1,100
| +9% | +$109K |
|
1365
Neurocrine Biosciences
NBIX
$17.7B
| $1.36M | ﹤0.01% |
12,638
+5,099
| +68% | +$534K |
|
|
X
1366
DELISTED
US Steel
X
| $1.35M | ﹤0.01% |
117,927
+42,259
| +56% | +$525K |
|
1367
California Water Service
CWT
$3.04B
| $1.34M | ﹤0.01% |
25,966
-191,233
| -88% | -$9.98M |
|
1368
Cognex
CGNX
$10.3B
| $1.34M | ﹤0.01% |
+23,854
| New | +$1.23M |
|
1369
Hudbay
HBM
$9.92B
| $1.33M | ﹤0.01% |
321,303
-61,561
| -16% | -$223K |
|
1370
Credit Acceptance
CACC
$6B
| $1.33M | ﹤0.01% |
3,011
+1,158
| +62% | +$510K |
|
1371
StoneCo
STNE
$2.62B
| $1.33M | ﹤0.01% |
33,333
+8,788
| +36% | +$321K |
|
|
VISN
1372
Vistance Networks Inc
VISN
$2.66B
| $1.32M | ﹤0.01% |
93,195
+78,195
| +521% | +$1.01M |
|
1373
Trade Desk
TTD
$8.13B
| $1.32M | ﹤0.01% |
50,900
-18,680
| -27% | -$420K |
|
1374
Allogene Therapeutics
ALLO
$601M
| $1.32M | ﹤0.01% |
+50,767
| New | +$1.4M |
|
|
GBT
1375
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.32M | ﹤0.01% |
16,565
-38,488
| -70% | -$2.28M |
|
Similar funds
Man Group's Q4 2019 Portfolio in Review
As of Q4 2019, Man Group held 1,992 positions worth $30.4B, up 13% from $26.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Man Group's Q4 2019 filing shows 240 new, 827 increased, 644 reduced and 177 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 1,207,475 shares worth $54.2M. The largest sale was Expedia Group, an estimated $177M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Man Group's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 1,207,475 shares worth $54.2M.
- Man Group added most to Procter & Gamble in Q4 2019, an estimated $151M increase.
- Man Group's biggest Q4 2019 reduction was Expedia Group, cutting an estimated $177M.
- Man Group fully exited Celgene Corp in Q4 2019, selling an estimated $47.9M.
- Man Group's ten largest holdings make up 10% of its $30.4B portfolio in Q4 2019.
- Man Group opened 240 new positions and closed 177 in Q4 2019.
- Man Group's portfolio value rose 13% quarter-over-quarter to $30.4B.
Based on Man Group's 13F filing for Q4 2019, filed 18 Feb 2020.